Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Imunon, Inc. Director's Dealing 2016

Jun 16, 2016

35124_dirs_2016-06-16_63b7e06e-49a9-4a45-b733-8ebfb8a4c3ad.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2016-06-16

Reporting Person: Tardugno Michael H (Director, Chairman, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-06-16 Celsion Corporation Common Stock P 7500 $1.35 Acquired 128021 Direct

Footnotes

F1: The Chairman, President and Chief Executive Officer purchased the shares on the open market